Related Experiment Video

Updated: Aug 20, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients

Jiro Aoki1, Yuji Ikari, Hiroyoshi Nakajima

  • 1Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan. aokijiro@aol.com

Kidney International
|December 22, 2004
PubMed

Insights

Dialysis patients with dilated cardiomyopathy show severe heart muscle cell growth and fibrosis. Extensive heart fibrosis predicts cardiac death, necessitating close monitoring and treatment for these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pathology

Background:

  • Dialysis patients often exhibit impaired left ventricular (LV) function without coronary artery disease, but their specific pathological changes and prognoses remain poorly understood.
  • Dilated cardiomyopathy (DCM) in dialysis patients is characterized by reduced ejection fraction and enlarged LV end-diastolic volume index.
  • The underlying cardiac pathology in this population requires further elucidation.

Purpose of the Study:

  • To investigate the pathological characteristics of the left ventricle in hemodialysis patients with DCM.
  • To determine the prognostic significance of these pathological findings, particularly left ventricular fibrosis, in relation to cardiac death.

Main Methods:

  • Left ventricular endomyocardial biopsies were performed on 40 hemodialysis patients with DCM and 50 non-dialysis patients with idiopathic DCM (control group).
  • Patients were followed for a mean of 3.1 years post-biopsy.
  • Pathological features including myocyte hypertrophy, disarray, and fibrosis were assessed and correlated with clinical outcomes.

Main Results:

  • Hemodialysis patients with DCM exhibited significantly severe myocyte hypertrophy and extensive interstitial fibrosis compared to controls, resembling the dilated phase of hypertrophic cardiomyopathy.
  • A high percentage of left ventricular fibrosis was identified as the sole significant predictor of cardiac death in multivariate analysis (P=0.02).
  • The 3-year event-free survival for cardiac death was markedly lower in dialysis patients with severe fibrosis (42%) versus those without (82%).

Conclusions:

  • The primary cardiac pathologies in dialysis patients with DCM include interstitial fibrosis and severe myocyte hypertrophy.
  • The extent of left ventricular fibrosis is a critical prognostic indicator for cardiac mortality in this patient group.
  • Dialysis patients with significant left ventricular fibrosis require vigilant follow-up and tailored therapeutic strategies to mitigate cardiac event risk.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...